+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global CMO Market in Pharmaceutical Industry 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • November 2021
  • Region: Global
  • TechNavio
  • ID: 5514987
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the CMO market in the pharmaceutical industry and it is poised to grow by $46.69 bn during 2022-2026, progressing at a CAGR of 7.41% during the forecast period. The report on the CMO market in the pharmaceutical industry provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of cost-efficient resources in emerging markets and strong research funding.

The CMO market in pharmaceutical industry analysis includes the service segment and geographic landscape.

The CMO market in pharmaceutical industry is segmented as below:


By Service

  • API manufacturing service
  • FDF manufacturing service

By Geographical Landscape

  • Europe
  • North America
  • APAC
  • MEA
  • South America

This study identifies the growing need to focus on core competencies as one of the prime reasons driving the CMO market in pharmaceutical industry growth during the next few years.

The report on CMO market in pharmaceutical industry covers the following areas:

  • CMO market in pharmaceutical industry sizing
  • CMO market in pharmaceutical industry forecast
  • CMO market in pharmaceutical industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CMO market in pharmaceutical industry vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CMIC HOLDINGS Co. LTD., Curia Inc., Dr. Reddys Laboratories Ltd., Lonza Group Ltd., Lupin Ltd., Pfizer Inc., and Thermo Fisher Scientific Inc. Also, the CMO market in pharmaceutical industry analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2021
  • Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Service
  • Market segments
  • Comparison by Service
  • API manufacturing service - Market size and forecast 2021-2026
  • FDF manufacturing service - Market size and forecast 2021-2026
  • Market opportunity by Service

Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2021-2026
  • North America - Market size and forecast 2021-2026
  • APAC - Market size and forecast 2021-2026
  • MEA - Market size and forecast 2021-2026
  • South America - Market size and forecast 2021-2026
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • CMIC HOLDINGS Co. LTD.
  • Curia Inc.
  • Dr. Reddys Laboratories Ltd.
  • Lonza Group Ltd.
  • Lupin Ltd.
  • Pfizer Inc.
  • Thermo Fisher Scientific Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2021 - 2026 ($ billion)
  • Global market: Year-over-year growth 2021 - 2026 (%)
  • Five forces analysis 2021 & 2026
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2021
  • Service - Market share 2021-2026 (%)
  • Comparison by Service
  • API manufacturing service - Market size and forecast 2021-2026 ($ billion)
  • API manufacturing service - Year-over-year growth 2021-2026 (%)
  • FDF manufacturing service - Market size and forecast 2021-2026 ($ billion)
  • FDF manufacturing service - Year-over-year growth 2021-2026 (%)
  • Market opportunity by Service
  • Customer landscape
  • Market share By Geographical Landscape 2021-2026 (%)
  • Geographic comparison
  • Europe - Market size and forecast 2021-2026 ($ billion)
  • Europe - Year-over-year growth 2021-2026 (%)
  • North America - Market size and forecast 2021-2026 ($ billion)
  • North America - Year-over-year growth 2021-2026 (%)
  • APAC - Market size and forecast 2021-2026 ($ billion)
  • APAC - Year-over-year growth 2021-2026 (%)
  • MEA - Market size and forecast 2021-2026 ($ billion)
  • MEA - Year-over-year growth 2021-2026 (%)
  • South America - Market size and forecast 2021-2026 ($ billion)
  • South America - Year-over-year growth 2021-2026 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Almac Group Ltd. - Overview
  • Almac Group Ltd. - Product and service
  • Almac Group Ltd. - Key offerings
  • Almac Group Ltd. - Key customers
  • Almac Group Ltd. - Segment focus
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Business segments
  • Boehringer Ingelheim International GmbH - Key offerings
  • Boehringer Ingelheim International GmbH - Key customers
  • Boehringer Ingelheim International GmbH - Segment focus
  • Cadila Pharmaceuticals Ltd. - Overview
  • Cadila Pharmaceuticals Ltd. - Product and service
  • Cadila Pharmaceuticals Ltd. - Key offerings
  • Cadila Pharmaceuticals Ltd. - Key customers
  • Cadila Pharmaceuticals Ltd. - Segment focus
  • CMIC HOLDINGS Co. LTD. - Overview
  • CMIC HOLDINGS Co. LTD. - Business segments
  • CMIC HOLDINGS Co. LTD. - Key offerings
  • CMIC HOLDINGS Co. LTD. - Key customers
  • CMIC HOLDINGS Co. LTD. - Segment focus
  • Curia Inc. - Overview
  • Curia Inc. - Product and service
  • Curia Inc. - Key offerings
  • Curia Inc. - Key customers
  • Curia Inc. - Segment focus
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Key customers
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Key customers
  • Lonza Group Ltd. - Segment focus
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Product and service
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Key customers
  • Lupin Ltd. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global CMO market in pharmaceutical industry: Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CMIC HOLDINGS Co. LTD., Curia Inc., Dr. Reddys Laboratories Ltd., Lonza Group Ltd., Lupin Ltd., Pfizer Inc., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing need to focus on core competencies.`

According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • CMIC HOLDINGS Co. LTD.
  • Curia Inc.
  • Dr. Reddys Laboratories Ltd.
  • Lonza Group Ltd.
  • Lupin Ltd.
  • Pfizer Inc.
  • Thermo Fisher Scientific Inc.